Beatt K J, Serruys P W, Luijten H E, Rensing B J, Suryapranata H, de Feyter P, van den Brand M, Laarman G J, Roelandt J
Catheterization Laboratory, Erasmus University Rotterdam, The Netherlands.
J Am Coll Cardiol. 1992 Feb;19(2):258-66. doi: 10.1016/0735-1097(92)90475-3.
Restenosis after coronary angioplasty is the single complication that most limits this revascularization procedure in clinical practice. The process is largely unpredictable and the lesion-related factors predisposing to restenosis are poorly understood, with little consensus in published reports. In this study using detailed quantitative angiographic measurements to assess 490 lesions, the simple lesion characteristics associated with restenosis were defined and the relation to the restenosis process documented. Restenosis was defined as an absolute deterioration in the minimal lumen diameter by greater than or equal to 0.72 mm, a criterion based on the 95% confidence intervals for repeat angiographic measurements. This was chosen in an attempt to separate spurious changes due to a poor angiographic result and the variability of angiographic measurements from significant changes due to the restenosis process. The principal determinants of restenosis were found to be a large improvement in the minimal lumen diameter at the time of dilation (1.13 mm for the restenosis group compared with 0.86 mm for the no restenosis group [p less than 0.0001]) and an optimal postangioplasty result (minimal lumen diameter 2.28 mm in the restenosis group compared with 2.05 mm [p less than 0.001] in the no restenosis group, corresponding to a 25% and a 30% diameter stenosis, respectively [p less than 0.0001]). These observations reported for the first time suggest that the distinction needs to be made between a "clinical restenosis" of greater than or equal to 50% diameter stenosis and the "restenosis process" as measured by the absolute changes occurring during and after angioplasty.(ABSTRACT TRUNCATED AT 250 WORDS)
冠状动脉血管成形术后再狭窄是临床实践中最限制这种血运重建手术的单一并发症。该过程在很大程度上不可预测,且对易导致再狭窄的病变相关因素了解甚少,已发表的报告中也几乎没有共识。在本研究中,使用详细的定量血管造影测量来评估490个病变,定义了与再狭窄相关的简单病变特征,并记录了其与再狭窄过程的关系。再狭窄定义为最小管腔直径绝对恶化大于或等于0.72毫米,该标准基于重复血管造影测量的95%置信区间。选择此标准是为了将因血管造影结果不佳和血管造影测量变异性导致的虚假变化与因再狭窄过程导致的显著变化区分开来。研究发现,再狭窄的主要决定因素是扩张时最小管腔直径有大幅改善(再狭窄组为1.13毫米,无再狭窄组为0.86毫米[p<0.0001])以及血管成形术后结果理想(再狭窄组最小管腔直径为2.28毫米,无再狭窄组为2.05毫米[p<0.001],分别对应25%和30%的直径狭窄[p<0.0001])。首次报道的这些观察结果表明,需要区分直径狭窄大于或等于50%的“临床再狭窄”和血管成形术期间及术后发生的绝对变化所衡量的“再狭窄过程”。(摘要截取自250字)